Golden State Wealth Management, LLC Immunity Bio, Inc. Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 700 shares of IBRX stock, worth $2,212. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700Holding current value
$2,212% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
206Shares Held
70MCall Options Held
1.64MPut Options Held
1.31M-
Vanguard Group Inc Valley Forge, PA16.9MShares$53.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$36.1 Million0.0% of portfolio
-
State Street Corp Boston, MA8.65MShares$27.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.85MShares$12.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.25MShares$7.1 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.26B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...